A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...
Researchers have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal neurodegenerative condition. The treatment, which uses ...
Looking at Firefly’s year-to-date (YTD) performance, the company has shown an incredible gain of +38.49%. In comparison, the broader market, as represented by the S&P 500, is down -1.61% YTD. This ...